EMCDDA news

New EMCDDA report shows grounds for hope in treating hepatitis C

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks at new opportunities for the effective prevention and treatment of hepatitis C. World Hepatitis Day — hepatitis C among drug users in Europe 28.07.2016 
Read more

European Parliament LIBE Committee members pay fact-finding visit to the EMCDDA

Members of the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) start a two-day visit to the EMCDDA today where they will hear presentations on the agency’s contribution to a more secure and a healthier Europe. European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) 12.07.2016 
Read more

EMCDDA Director at German Bundestag hearing on new psychoactive substances

06.07.2016  EMCDDA Director Alexis Goosdeel is in Berlin today where he is speaking at a public hearing at the German Parliament (Bundestag) on the issue of new psychoactive substances (NPS). The hearing is organised by the Bundestag Health Committee and chaired by Dr Edgar Franke (Member of the German Parliament).
Read more